FDA Approved Products

1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: PeakClear all
ADEMPAS
riociguat
Peak
Bayer
ORAL · TABLET
inoperable CTEPH to improve exercise capacityfunctional class+6
2013
NDA
0/100
ADHANSIA XR
methylphenidate hydrochloride
Peak
Purdue Pharma
ORAL · CAPSULE, EXTENDED RELEASE
attention deficit hyperactivitydisorder (ADHD) in patients aged 6 to 65 years oldattention deficit hyperactivity disorder (ADHD) in patients aged 6 to 65 years old
2019
NDA
0/100
ADLARITY
donepezil hydrochloride
Peak
TRANSDERMAL · SYSTEM
dementia of the Alzheimer's typeAlzheimer's disease
2022
NDA
0/100
ADRENALIN
epinephrine
Peak
Pfizer
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS · SOLUTION
2012
NDA
0/100
ADRENALIN
epinephrine
Peak
Pfizer
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS · SOLUTION
2013
NDA
0/100
ADVIL DUAL ACTION WITH ACETAMINOPHEN
ibuprofen, acetaminophen
Peak
GSK
ORAL · TABLET
2020
NDA
0/100
ADZENYS ER
amphetamine
Peak
Therapeutic Solutions International
ORAL · SUSPENSION, EXTENDED RELEASE
Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 yearsolder
2017
NDA
0/100
ADZENYS XR-ODT
amphetamine extended-release
Peak
Therapeutic Solutions International
ORAL · TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE
Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 yearsolder
2016
NDA
0/100
AIRDUO DIGIHALER
fluticasone propionate and salmeterol
Peak
Teva
INHALATION · POWDER
asthma in adultolder+4
2017
NDA
0/100
AIRDUO RESPICLICK
fluticasone propionate and salmeterol
Peak
Teva
INHALATION · POWDER
asthma in adultolder+4
2017
NDA
0/100
AKLIEF
trifarotene
Peak
Galderma
TOPICAL · CREAM
2019
NDA
0/100
AKYNZEO
netupitant and palonosetron
Peak
Helsinn
ORAL · CAPSULE
combination with dexamethasone in adults for the prevention of acutedelayed nausea+6
2014
NDA
0/100
AKYNZEO
fosnetupitant and palonosetron
Peak
Helsinn
INTRAVENOUS · SOLUTION
combination with dexamethasone in adults for the prevention of acutedelayed nausea+6
2018
NDA
0/100
ALECENSA
alectinib hydrochloride
Peak
Roche
ORAL · CAPSULE
lung cancerlymphoma
2015
NDA
0/100
ALIQOPA
copanlisib dihydrochloride
Peak
Bayer
INTRAVENOUS · POWDER
2017
NDA
0/100
ALKINDI SPRINKLE
hydrocortisone
Peak
ORAL · GRANULE
2020
NDA
0/100
ALTRENO
tretinoin
Peak
TOPICAL · LOTION
2018
NDA
0/100
ALUNBRIG
brigatinib
Peak
Takeda
ORAL · TABLET
lung cancerlymphoma
2017
SMNDA
0/100
AMELUZ
aminolevulinic acid hydrochloride
Peak
Biofrontera
TOPICAL · GEL
2016
NDA
0/100
AMVUTTRA
vutrisiran
Peak
Alnylam Pharmaceuticals
SUBCUTANEOUS · SOLUTION
the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adultsthe cardiomyopathy of wild-type+4
2022
RNANDA
0/100
AMZEEQ
minocycline
Peak
Journey Medical
TOPICAL · AEROSOL, FOAM
inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 9 years of ageolder+2
2019
SMNDA
0/100
ANGELIQ
drospirenone and estradiol
Peak
Bayer
ORAL · TABLET
moderate to severe vasomotor symptoms due to menopause in a woman with a uterusmoderate to severe vasomotor symptoms associated due to menopause in a woman with a uterus+3
2005
NDA
0/100
ANGIOMAX RTU
bivalirudin
Peak
MAIA Biotechnology
INTRAVENOUS · SOLUTION
2019
NDA
0/100
ANJESO
meloxicam
Peak
INTRAVENOUS · SOLUTION
Rheumatoid Arthritis
2020
NDA
0/100
← PreviousPage 25 of 55Next →